US 8563576
Tri-cyclic pyrazolopyridine kinase inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8563576 (Tri-cyclic pyrazolopyridine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/06, A61P17/02